Phase II Trial of Antiepidermal Growth Factor Receptor Antibody C225 in Patients with Advanced Renal Cell Carcinoma
Year: 2003
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Yale University, Fox Chase Cancer Center, University of Virginia Health System, University of Virginia, Vall d'Hebron Hospital Universitari, University of Vermont, University of Alabama, University of Alabama at Birmingham, Bristol-Myers Squibb (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W117475386